Max Healthcare

The CGHS revision is positive for private healthcare operators and will disproportionately benefit super-specialty hospitals, noted analysts.

Fortis, Max Healthcare, other hospital stocks rise up to 7% as govt revises medical procedures rates

Global brokerage Macquarie sees procedure rates in key therapy areas of cardiology, neurology, oncology, orthopedic rising by 5%-30%

Max Healthcare likely to see buying from active funds on Nifty inclusion, is it a good bet? 

According to Elara Capital, active funds are underweight on Max Healthcare player by roughly Rs 11,743 crore; the Nifty inclusion will likely spur buying.

Nifty rejig tomorrow: Max Health, IndiGo likely to enter index, IndusInd Bank and Hero Moto may exit

The official decision by the NSE Index sub-committee is expected on August 22. The index adjustments, effective September 29, 2025 will be closely watched as several passive funds that track the benchmark could see changes in their fund flow allocations.

Max Healthcare to invest Rs 170-200 crore in a 130-bed hospital in Dehradun

The existing hospital in the city is running at an occupancy of over 80 percent, and hence, there is 'dire need to expand the capacity of tertiary care beds in the city', said Max Healthcare. The facility will cater to the healthcare needs of people in Dehradun and surrounding regions.

This hospital chain is aiming for high growth, but is it already priced in?

Max is on an aggressive expansion path with healthy medium-term growth visibility

Max Healthcare's billionaire MD on Donald Trump's $5 million 'gold card' offer: 'Wouldn’t want to...'

A major drawback for the 'gold card' has been US' tax implication. The country taxes its citizens on their income around the world, regardless of where they live. Interestingly, Abhay Soi has been paid about Rs 400 crore in income tax in 2022-23.

Max Healthcare shares gain 3% as UBS upgrades to 'buy', sees 18% upside

Max Healthcare share price: Analysts suggest that Max Healthcares' plan to double its bed capacity within the next three years is expected to further enhance its growth prospects.

Max Healthcare: Quick turnaround in acquired assets makes us positive on the stock

The company appears well-positioned to gain from sectoral tailwinds, with its focus on expanding presence in key markets, and being a preferred service provider for international patients

Max Healthcare stock soars 4% after firm completes acquisition of Jaypee Hospital

This acquisition grants Max Healthcare control of Jaypee's 500-bed Noida hospital, as well as two other hospitals in UP’s Bulandshahr and Anoopshahr.

Buy Max Healthcare; target of Rs 1240: Motilal Oswal

Motilal Oswal is bullish on Max Healthcare has recommended buy rating on the stock with a target price of Rs 1240 in its research report dated November 07, 2024.

Diwali stock picks 2024: Ambuja Cement, ICICI Bank, RIL among PL Capital's top bets for Samvat 2081

Stocks to buy this Diwali: Analysts at Prabhudas Lilladher chose stocks like ICICI Bank, Reliance Industries and Bharat Electronics among others as their preferred bets for Samvat 2081

Buy Max Healthcare; target of Rs 1240: Motilal Oswal

Motilal Oswal is bullish on Max Healthcare recommended buy rating on the stock with a target price of Rs 1240 in its research report dated September 20, 2024.

Max Healthcare: A healthy but pricey stock

The healthcare company’s medium-term revenue growth visibility appears healthy

Short Call | About bottomlines and trendlines: Mutual Funds dump titans, chase the new cool! StoveKraft, Macrotech in focus

The whole institutional structure of the marketplace rests on the assumption that the other side of the trade will always be there; without that assumption, even the gutsiest of market-makers would refuse to stay in business - Peter Bernstein

Max Healthcare acquires struggling Jaypee Hospital at Rs 1,660 crore enterprise value

The proposed acquisition will give Max Healthcare a controlling stake in JHL, including its flagship asset, the 500-bed Jaypee Hospital in Noida.

Should you place your bet on the Max Healthcare stock?

Near-term earnings outlook remains supportive. However, valuations are elevated.